{"pmid":32492212,"title":"Re-test Positive for SARS-CoV-2 RNA of \"Recovered\" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?","text":["Re-test Positive for SARS-CoV-2 RNA of \"Recovered\" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?","\"Re-test Positive\" for SARS-CoV-2 from \"recovered\" COVID-19 has been reported and raised several important questions for this novel coronavirus and COVID-19 disease. In this commentary, we discussed several questions: 1. Can SARS-CoV-2 re-infect the individuals who recovered from COVID-19? This question is also associated with other questions: whether or not SARS-CoV-2 infection induces protective reaction or neutralized antibody? Will SARS-CoV-2 vaccines work? 2. Why could some recovered COVID-19 patients be re-tested positive for SARS-CoV-2 RNA? 3. Are some recovered COVID-19 patients with re-testing positive for SARS-CoV-2 RNA infectious? 4. How should the COVID-19 patients with re-test positive for SARS-CoV-2 be managed? This article is protected by copyright. All rights reserved.","J Med Virol","Kang, Hanyujie","Wang, Yishan","Tong, Zhaohui","Liu, Xuefeng","32492212"],"abstract":["\"Re-test Positive\" for SARS-CoV-2 from \"recovered\" COVID-19 has been reported and raised several important questions for this novel coronavirus and COVID-19 disease. In this commentary, we discussed several questions: 1. Can SARS-CoV-2 re-infect the individuals who recovered from COVID-19? This question is also associated with other questions: whether or not SARS-CoV-2 infection induces protective reaction or neutralized antibody? Will SARS-CoV-2 vaccines work? 2. Why could some recovered COVID-19 patients be re-tested positive for SARS-CoV-2 RNA? 3. Are some recovered COVID-19 patients with re-testing positive for SARS-CoV-2 RNA infectious? 4. How should the COVID-19 patients with re-test positive for SARS-CoV-2 be managed? This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kang, Hanyujie","Wang, Yishan","Tong, Zhaohui","Liu, Xuefeng"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492212","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26114","keywords":["coronavirus < virus classification","disease control","immunity/immunization < epidemiology","persistent infection < infection","sars coronavirus < virus classification"],"topics":["Diagnosis"],"weight":1,"_version_":1668892169229828096,"score":9.490897,"similar":[{"pmid":32369214,"title":"Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.","text":["Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.","The number of hospitalized cases has declined significantly in Wuhan. However, there have been reports that several cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients, the potential reasons of re-detectable positive patients remained elusive. Here, we report three confirmed cases of COVID-19 whose IgM was negative and IgG was positive before the first discharge, while nasopharyngeal swab test of SARS-CoV-2 RNA turned positive again during hotel isolation. In addition, all three cases presented negative results for IgM antibodies and positive results for IgG antibodies during re-admission period. These cases suggested that the reasons for re-detectable positive patients with profile of antibodies may be related to several factors. It is necessary to quarantine COVID-19 patients for 14 days after discharge, and the role of antibodies in anti-SARS-CoV-2 warrants further investigation. This article is protected by copyright. All rights reserved.","J Med Virol","Fu, Wei","Chen, Qian","Wang, Tao","32369214"],"abstract":["The number of hospitalized cases has declined significantly in Wuhan. However, there have been reports that several cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients, the potential reasons of re-detectable positive patients remained elusive. Here, we report three confirmed cases of COVID-19 whose IgM was negative and IgG was positive before the first discharge, while nasopharyngeal swab test of SARS-CoV-2 RNA turned positive again during hotel isolation. In addition, all three cases presented negative results for IgM antibodies and positive results for IgG antibodies during re-admission period. These cases suggested that the reasons for re-detectable positive patients with profile of antibodies may be related to several factors. It is necessary to quarantine COVID-19 patients for 14 days after discharge, and the role of antibodies in anti-SARS-CoV-2 warrants further investigation. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Fu, Wei","Chen, Qian","Wang, Tao"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369214","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/jmv.25968","keywords":["antibody","covid-19","rna","sars-cov-2"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138496138477570,"score":326.04187},{"pmid":32449789,"title":"Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.","text":["Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.","Recurrence of positive SARS CoV-2 PCR has been described in patients discharged from hospital after 2 consecutive negative PCR. We discuss possible explanations including false negative, reactivation and re-infection and propose different strategy to solve this issue. Prolonged SARS-CoV-2 RNA shedding and recurrence of viral RNA shedding in asymptomatic patients remain unknown. Transmission of SARS-CoV-2 by asymptomatic carriers had been documented. Considering the significance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of potential SARS-CoV-2 recurrence in COVID-19 patients. This article is protected by copyright. All rights reserved.","J Med Virol","Hoang, Van Thuan","Dao, Thi Loi","Gautret, Philippe","32449789"],"abstract":["Recurrence of positive SARS CoV-2 PCR has been described in patients discharged from hospital after 2 consecutive negative PCR. We discuss possible explanations including false negative, reactivation and re-infection and propose different strategy to solve this issue. Prolonged SARS-CoV-2 RNA shedding and recurrence of viral RNA shedding in asymptomatic patients remain unknown. Transmission of SARS-CoV-2 by asymptomatic carriers had been documented. Considering the significance of this ongoing global public health emergency, it is necessary to carry out large studies to better understand the issue of potential SARS-CoV-2 recurrence in COVID-19 patients. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Hoang, Van Thuan","Dao, Thi Loi","Gautret, Philippe"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32449789","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26056","keywords":["coronavirus < virus classification","culture < social science","genetics","sars coronavirus < virus classification"],"topics":["Diagnosis"],"weight":1,"_version_":1667785213888954368,"score":288.79025},{"pmid":32270882,"title":"False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","text":["False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.","A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved.","J Med Virol","Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng","32270882"],"abstract":["A novel coronavirus (COVID-19) pandemic cause by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) threatens the world. We read with interest the recent report by Li et al. that included 610 patients with Coronavirus Disease 2019 (COVID-19). They reported a high false-negative rate of real-time reverse transcription polymerase chain reaction (RT-PCR) results for SARS-CoV-2 detection. In addition, recent report regarding SARS-CoV-2 \"turn positive\" in recovered cases with COVID-19 were published. Here, we studied the characteristics of nucleic acid conversion for SARS-CoV-2 from 70 COVID-19 patients. We found that 15 (21.4%) patients experienced a \"turn positive\" of nucleic acid detection by RT-PCR test for SARS-CoV-2 after two consecutive negative results, which may be related to the false negative of RT-PCR test and prolonged nucleic acid conversion This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Xiao, Ai Tang","Tong, Yi Xin","Zhang, Sheng"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270882","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25855","keywords":["coronavirus < virus classification","sars coronavirus < virus classification","shedding < pathogenesis"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491747041283,"score":224.65373},{"pmid":32484958,"title":"Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.","text":["Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.","COVID-19 patients may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the SARS-CoV-2 viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative RT-PCR tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than two weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. This article is protected by copyright. All rights reserved.","J Med Virol","Carmo, Analia","Pereira-Vaz, Joao","Mota, Vanda","Mendes, Alexandra","Morais, Celia","da Silva, Andreia Coelho","Camilo, Elisabete","Pinto, Catarina Silva","Cunha, Elizabete","Pereira, Janet","Coucelo, Margarida","Martinho, Patricia","Correia, Lurdes","Marques, Gilberto","Araujo, Lucilia","Rodrigues, Fernando","32484958"],"abstract":["COVID-19 patients may be discharged based on clinical resolution of symptoms, and evidence for viral RNA clearance from the upper respiratory tract. Understanding the SARS-CoV-2 viral clearance profile is crucial to establish a re-testing plan on discharge and ending isolation of patients. We aimed to evaluate the number of days that a patient needed to achieve undetectable levels of SARS-CoV-2 in upper respiratory tract specimens (nasopharyngeal swab and/or an oropharyngeal swab). The clearance and persistence of viral RNA was evaluated in two groups of positive patients: those who achieved two negative RT-PCR tests and those who kept testing positive. Patients were organized thereafter in two subgroups, mild illness patients discharged home and inpatients who had moderate to severe illness. Results from RT-PCR tests were then correlated with results from the evaluation of the immune response. The study evidenced that most patients tested positive for more than two weeks and that persistence of viral RNA is not necessarily associated with severe disease but may result from a weaker immune response instead. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Carmo, Analia","Pereira-Vaz, Joao","Mota, Vanda","Mendes, Alexandra","Morais, Celia","da Silva, Andreia Coelho","Camilo, Elisabete","Pinto, Catarina Silva","Cunha, Elizabete","Pereira, Janet","Coucelo, Margarida","Martinho, Patricia","Correia, Lurdes","Marques, Gilberto","Araujo, Lucilia","Rodrigues, Fernando"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32484958","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26103","keywords":["covid-19","rt-pcr","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1668532114697486336,"score":222.6823},{"pmid":32311142,"title":"Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","text":["Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.","The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.","J Med Virol","Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong","32311142"],"abstract":["The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Wu, Xiaodong","Fu, Bo","Chen, Lang","Feng, Yong"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311142","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25904","keywords":["coronavirus < virus classification","humoral immunity < immune responses","inapparent infection < epidemiology"],"locations":["Wuhan","Qingshan Destrict","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491155644416,"score":222.2648}]}